Facial Filler Coverage Will Help Boost Quality Of Life For HIV Patients - CMS
This article was originally published in The Gray Sheet
Executive Summary
In a March 23 decision memo, CMS says it will now cover dermal injections to treat facial lipodystrophy when the stigmatizing side effect of antiretroviral HIV drugs is a significant contributor to a Medicare beneficiary's depression
You may also be interested in...
HIV Patient Advocates Want Facial-Filler Option, Irrespective Of Depression
Psychologists, social workers and patient advocates are applauding a CMS proposal to cover dermal filler treatments for HIV patients with symptoms of facial wasting, a common side effect of medical treatment
HIV Screening Tests Gain Coverage Under CMS Preventive Services Authority
CMS will cover standard laboratory and rapid HIV screening tests for certain Medicare patients, the agency said in a Dec. 8 national coverage determination
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.